Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

1.
2.

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.

Levitan B, Yuan Z, Turpie AG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM.

Vasc Health Risk Manag. 2014 Mar 26;10:157-67. doi: 10.2147/VHRM.S54714. eCollection 2014.

PMID:
24707185
[PubMed - in process]
Free PMC Article
3.

Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends.

Budhiparama NC, Abdel MP, Ifran NN, Parratte S.

Curr Rev Musculoskelet Med. 2014 Jun;7(2):108-16. doi: 10.1007/s12178-014-9207-1.

PMID:
24706152
[PubMed]
4.

Thromboprophylaxis only during hospitalisation in fast-track hip and knee arthroplasty, a prospective cohort study.

Jørgensen CC, Jacobsen MK, Soeballe K, Hansen TB, Husted H, Kjærsgaard-Andersen P, Hansen LT, Laursen MB, Kehlet H.

BMJ Open. 2013 Dec 10;3(12):e003965. doi: 10.1136/bmjopen-2013-003965.

PMID:
24334158
[PubMed]
Free PMC Article
5.

The discovery of rivaroxaban: translating preclinical assessments into clinical practice.

Kubitza D, Perzborn E, Berkowitz SD.

Front Pharmacol. 2013 Nov 25;4:145. doi: 10.3389/fphar.2013.00145. Review.

PMID:
24324436
[PubMed]
Free PMC Article
6.

Effect of co-administration of rivaroxaban and clopidogrel on bleeding time, pharmacodynamics and pharmacokinetics: a phase I study.

Kubitza D, Becka M, Mück W, Schwers S.

Pharmaceuticals (Basel). 2012 Feb 24;5(3):279-96. doi: 10.3390/ph5030279.

PMID:
24281379
[PubMed]
Free PMC Article
7.
8.

Practical management of new oral anticoagulants after total hip or total knee arthroplasty.

Klauser W, Dütsch M.

Musculoskelet Surg. 2013 Dec;97(3):189-97. doi: 10.1007/s12306-013-0306-8. Epub 2013 Nov 19.

PMID:
24249360
[PubMed - in process]
Free PMC Article
9.

A new paradigm shift in antithrombotic therapy.

Pudusseri A, Shameem R, Spyropoulos AC.

Front Pharmacol. 2013 Oct 21;4:133. doi: 10.3389/fphar.2013.00133. Review.

PMID:
24155721
[PubMed]
Free PMC Article
10.

An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.

Cove CL, Hylek EM.

J Am Heart Assoc. 2013 Oct 23;2(5):e000136. doi: 10.1161/JAHA.113.000136. Review. No abstract available.

PMID:
24152980
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The new oral anticoagulants in atrial fibrillation: an update.

Verheugt FW.

Neth Heart J. 2013 Nov;21(11):480-4. doi: 10.1007/s12471-013-0473-0.

PMID:
24072689
[PubMed]
Free PMC Article
12.

The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature.

Tahir F, Riaz H, Riaz T, Badshah MB, Riaz IB, Hamza A, Mohiuddin H.

Thromb J. 2013 Sep 3;11(1):18. doi: 10.1186/1477-9560-11-18.

PMID:
24007323
[PubMed]
Free PMC Article
13.

Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban.

Mueck W, Stampfuss J, Kubitza D, Becka M.

Clin Pharmacokinet. 2014 Jan;53(1):1-16. doi: 10.1007/s40262-013-0100-7.

PMID:
23999929
[PubMed - in process]
Free PMC Article
14.
15.

Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Willmann S, Becker C, Burghaus R, Coboeken K, Edginton A, Lippert J, Siegmund HU, Thelen K, Mück W.

Clin Pharmacokinet. 2014 Jan;53(1):89-102. doi: 10.1007/s40262-013-0090-5.

PMID:
23912563
[PubMed - in process]
Free PMC Article
16.

Transitions of care in anticoagulated patients.

Michota F.

J Multidiscip Healthc. 2013 Jun 20;6:215-28. doi: 10.2147/JMDH.S44068. Print 2013.

PMID:
23818798
[PubMed]
Free PMC Article
17.
18.

Rivaroxaban for the treatment of pulmonary embolism.

Vanassche T, Verhamme P.

Adv Ther. 2013 Jun;30(6):589-606. doi: 10.1007/s12325-013-0041-4. Epub 2013 Jun 27. Review.

PMID:
23807375
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.

Alquwaizani M, Buckley L, Adams C, Fanikos J.

Curr Emerg Hosp Med Rep. 2013 Apr 21;1(2):83-97. Print 2013 Jun.

PMID:
23687625
[PubMed]
Free PMC Article
20.

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients.

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E.

Vasc Health Risk Manag. 2013;9:207-28. doi: 10.2147/VHRM.S35843. Epub 2013 May 8. Review.

PMID:
23674896
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk